Given the importance of curcumin in cancer treatment, several curcumin derivatives/analogs have been synthesized and studied over the past few years; however, only a few candidates have been studied as MDR modulators (by inhibiting P-gp function and/or P-gp expression). This evidence concerns the gene PGP and cancer.